Scientists from the ALICE collaboration at the LHC have announced the first evidence for antihyperhelium-4 nucleus detection.

Vertex Pharmaceuticals' shares dropped due to poor first-quarter results. Vertex's business and prospects remain attractive. Vertex Pharmaceuticals (NASDAQ: VRTX), a leading drugmaker, is ...

The ELT promises unprecedented views of the cosmos, exploring the origins of galaxies and the potential for life on exoplanets. When finished, it will be the world's largest optical telescope ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

In another departure from its core focus on genetic medicines, Vertex Pharma has agreed a $4.9 billion purchase of Alpine Immune Sciences, adding a mid-stage drug candidate for kidney disease IgA ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

It’s not every day that a space relic comes home. But this week, a forgotten Soviet spacecraft finally ended its long wait. After more than five decades in orbit, Kosmos 482 has returned to ...

The bubbly engineering student is among them and part of a young generation of South Africans now able to look into the cosmos since the 2018 inauguration of the MeerKAT super radio telescope ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

Vertex Minerals raising $11m to accelerate underground development at its Hill End gold project Capital raising provides remaining funds to take the project to underground mining in July 2025 Gold ...